Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules

Author(s):  Webster Kathy D, Al-Achi Antoine, Greenwood Robert

Issue:  Sep/Oct 1999 - Natural Hormone Replacement Therapy
View All Articles in Issue

Page(s):  409-411

In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Page 1
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Page 2
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Page 3

Download in electronic PDF format for $75

Abstract:  Morphine sulfate is a commonly prescribed drug for the relief of pain. This study investigated the dissolution profile of extemporaneously prepared slow-release morphine-sulfate capsules and MS ContinĀ® (Purdue Frederick, Norwalk, CT). Extemporaneously prepared capsules obtained from one pharmacist were compared with MS Contin tablets. In addition, we compared capsules prepared by 15 different pharmacists and three different batches prepared by the same pharmacist. A dissolution test1 was used to generate the dissolution profile for drug products. The compounded capsules demonstrated a slow-release profile that was similar to the commercial preparation except that the morphine sulfate was released at a faster rate. The zero-order dissolution rate constant (k0, milligrams/ hour) was calculated from the dissolution profiles. Statistical analysis of k0 showed that capsules prepared extemporaneously by pharmacist one showed a faster dissolution compared to MS Contin (p=0.0368); the difference was a rate of 0.81 mg/hour during the first four hours. When variability among compounding pharmacists was compared, only one batch of compounded capsules prepared from 15 different pharmacies showed a significantly different rate of morphine release. When reproducibility by a single pharmacist was examined, capsules showed some variation from batch to batch (p=0.05). Although variation was seen from one pharmacy to another and even between different batches made by the same pharmacist, the compounded capsules showed a remarkably consistent in vitro slow-release profile.

Related Keywords: dissolution, morphine sulfate, MS Contin, pain, slow release

Related Categories: PAIN MANAGEMENT, PEER-REVIEWED

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules
Webster Kathy D
, Al-Achi Antoine, Greenwood Robert
Sep/Oct 1999
Pg. 409-411

Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H
, Szwejkowski Jessica, Houston Alana
Sep/Oct 2001
Pg. 401-405

In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride
Glowiak Dana L
, Green Julie L, Bowman Bill J
Mar/Apr 2005
Pg. 157-164

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix
Timmons Evelyn D
, Timmons Steven P
Sep/Oct 2002
Pg. 379

Morphine Sulfate Slow-Release Suppositories
Allen Loyd V Jr
Jan/Feb 1997
Pg. 32-33

Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
Jan/Feb 2013
Pg. 10-22

Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes
Xu Quanyun A
, Trissel Lawrence A, Pham Lien
Jan/Feb 2002
Pg. 66-69

Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes
Trissel Lawrence A
, Xu Quanyun A, Pham Lien
Jan/Feb 2002
Pg. 70-73

Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization
Radojkovic Branko
, Milic Jela, Calija Bojan
Sep/Oct 2012
Pg. 434-437

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
Jul/Aug 2019
Pg. 318

Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches
Allen Loyd V Jr
Nov/Dec 2008
Pg. 549

Morphine Sulfate 10-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2009
Pg. 243

Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
May/Jun 2009
Pg. 244

Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes
Trissel Lawrence A
, Xu Quanyun A, Pham Lien
Jan/Feb 2002
Pg. 62-65

Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2005
Pg. 394

Triple Estrogen 2.5-mg Slow-Release Capsules
Allen Loyd V Jr
Sep/Oct 1999
Pg. 401

Oxycodone 25-mg Slow-Release Capsules
Allen Loyd V Jr
Jan/Feb 2002
Pg. 49

Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 545

Return to Top